Humanized mouse models in transplantation research

Transplantation Reviews

Volumn 28, Issue 3, 2014, Pages 103-110

  Hogenes, Marieke ^a   Huibers, Manon ^a   Kroone, Chantal ^a   de Weger, Roel ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GRAFT DYSFUNCTION; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; HUMANIZED MOUSE MODEL; MEDICAL RESEARCH; MOUSE MODEL; MOUSE STRAIN; NONHUMAN; REVIEW; TRANSPLANTATION; ANIMAL; DISEASE MODEL; HISTOCOMPATIBILITY; IMMUNOLOGY; MOUSE; TRANSLATIONAL RESEARCH;

ANIMALS; DISEASE MODELS, ANIMAL; GRAFT REJECTION; GRAFT VS HOST DISEASE; HUMANS; MICE; TRANSLATIONAL MEDICAL RESEARCH; TRANSPLANTATION IMMUNOLOGY;

EID: 84903741746     PISSN: 0955470X     EISSN: 15579816     Source Type: Journal    
DOI: 10.1016/j.trre.2014.02.002     Document Type: Review

References (81)

1. Malynn B.A., Blackwell T.K., Fulop G.M., et al. The scid defect affects the final step of the immunoglobulin VDJ recombinase mechanism. Cell 1988, 54:453-460.
2. Schuler W., Weiler I.J., Schuler A., et al. Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell 1986, 46:963-972.
3. McCune J.M., Namikawa R., Kaneshima H., Shultz L.D., Lieberman M., Weissman I.L. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988, 241:1632-1639.
4. Lapidot T., Pflumio F., Doedens M., Murdoch B., Williams D.E., Dick J.E. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 1992, 255:1137-1141.
5. Berney T., Molano R.D., Pileggi A., et al. Patterns of engraftment in different strains of immunodeficient mice reconstituted with human peripheral blood lymphocytes. Transplantation 2001, 72:133-140.
6. Tary-Lehmann M., Saxon A., Lehmann P.V. The human immune system in hu-PBL-SCID mice. Immunol Today 1995, 16:529-533.
7. Garcia S., Dadaglio G., Gougeon M.L. Limits of the human-PBL-SCID mice model: severe restriction of the V beta T-cell repertoire of engrafted human T cells. Blood 1997, 89:329-336.
8. Greiner D.L., Hesselton R.A., Shultz L.D. SCID mouse models of human stem cell engraftment. Stem Cells 1998, 16:166-177.
9. Fulop G.M., Phillips R.A. The scid mutation in mice causes a general defect in DNA repair. Nature 1990, 347:479-482.
10. Shiroki R., Poindexter N.J., Woodle E.S., Hussain M.S., Mohanakumar T., Scharp D.W. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection. Transplantation 1994, 57:1555-1562.
11. Olive C., Cheung C., Falk M.C. T cell engraftment in lymphoid tissues of human peripheral blood lymphocyte reconstituted SCID mice with or without prior activation of cells. Immunol Cell Biol 1998, 76:520-525.
12. Shibata S., Asano T., Noguchi A., Naito M., Ogura A., Doi K. Peritoneal macrophages play an important role in eliminating human cells from severe combined immunodeficient mice transplanted with human peripheral blood lymphocytes. Immunology 1998, 93:524-532.
13. Christianson S.W., Greiner D.L., Schweitzer I.B., et al. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice. Cell Immunol 1996, 171:186-199.
14. Mosier D.E., Stell K.L., Gulizia R.J., Torbett B.E., Gilmore G.L. Homozygous scid/scid;beige/beige mice have low levels of spontaneous or neonatal T cell-induced B cell generation. J Exp Med 1993, 177:191-194.
15. Shultz L.D., Schweitzer P.A., Christianson S.W., et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 1995, 154:180-191.
16. Greiner D.L., Shultz L.D., Yates J., et al. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. Am J Pathol 1995, 146:888-902.
17. Prochazka M., Gaskins H.R., Shultz L.D., Leiter E.H. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci U S A 1992, 89:3290-3294.
18. Christianson S.W., Greiner D.L., Hesselton R.A., et al. Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice. J Immunol 1997, 158:3578-3586.
19. de Sousa M., Reimao R., Lacerda R., Hugo P., Kaufmann S.H., Porto G. Iron overload in beta 2-microglobulin-deficient mice. Immunol Lett 1994, 39:105-111.
20. Steinsvik T.E., Gaarder P.I., Aaberge I.S., Lovik M. Engraftment and humoral immunity in SCID and RAG-2-deficient mice transplanted with human peripheral blood lymphocytes. Scand J Immunol 1995, 42:607-616.
21. Martin A., Valentine M., Unger P., Yeung S.W., Shultz L.D., Davies T.F. Engraftment of human lymphocytes and thyroid tissue into scid and rag2-deficient mice: absent progression of lymphocytic infiltration. J Clin Endocrinol Metab 1994, 79:716-723.
22. Shultz L.D., Lang P.A., Christianson S.W., et al. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J Immunol 2000, 164:2496-2507.
23. Ishikawa F., Yasukawa M., Lyons B., et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor gamma chain(null) mice. Blood 2005, 106:1565-1573.
24. Cao X., Shores E.W., Hu-Li J., et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 1995, 2:223-238.
25. Shultz L.D., Lyons B.L., Burzenski L.M., et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 2005, 174:6477-6489.
26. McDermott S.P., Eppert K., Lechman E.R., Doedens M., Dick J.E. Comparison of human cord blood engraftment between immunocompromised mouse strains. Blood 2010, 116:193-200.
27. Katano I., Ito R., Eto T., Aiso S., Ito M. Immunodeficient NOD-scid IL-2Rgamma(null) mice do not display T and B cell leakiness. Exp Anim 2011, 60:181-186.
28. Pearson T., Shultz L.D., Miller D., et al. Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment. Clin Exp Immunol 2008, 154:270-284.
29. Weijer K., Uittenbogaart C.H., Voordouw A., et al. Intrathymic and extrathymic development of human plasmacytoid dendritic cell precursors in vivo. Blood 2002, 99:2752-2759.
30. Buchner S.M., Sliva K., Bonig H., et al. Delayed onset of graft-versus-host disease in immunodeficent human leucocyte antigen-DQ8 transgenic, murine major histocompatibility complex class II-deficient mice repopulated by human peripheral blood mononuclear cells. Clin Exp Immunol 2013, 173:355-364.
31. Suzuki M., Takahashi T., Katano I., et al. Induction of human humoral immune responses in a novel HLA-DR-expressing transgenic NOD/Shi-scid/gammacnull mouse. Int Immunol 2012, 24:243-252.
32. Shultz L.D., Ishikawa F., Greiner D.L. Humanized mice in translational biomedical research. Nat Rev Immunol 2007, 7:118-130.
33. Shultz L.D., Brehm M.A., Garcia-Martinez J.V., Greiner D.L. Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol 2012, 12:786-798.
34. Mosier D.E., Gulizia R.J., Baird S.M., Wilson D.B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988, 335:256-259.
35. Traggiai E., Chicha L., Mazzucchelli L., et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004, 304:104-107.
36. Lepus C.M., Gibson T.F., Gerber S.A., et al. Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice. Hum Immunol 2009, 70:790-802.
37. Suzuki N., Yamazaki S., Yamaguchi T., et al. Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation. Mol Ther 2013, 21:1424-1431.
38. Pearson T., Greiner D.L., Shultz L.D. Creation of "humanized" mice to study human immunity. Curr Protoc Immunol 2008, 81:15.21.1-15.21.21.
39. Brehm M.A., Cuthbert A., Yang C., et al. Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation. Clin Immunol 2010, 135:84-98.
40. van Rijn R.S., Simonetti E.R., Hagenbeek A., et al. A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- gammac-/- double-mutant mice. Blood 2003, 102:2522-2531.
41. Nevozhay D., Opolski A. Key factors in experimental mouse hematopoietic stem cell transplantation. Arch Immunol Ther Exp (Warsz) 2006, 54:253-269.
42. Schroeder M.A., DiPersio J.F. Mouse models of graft-versus-host disease: advances and limitations. Dis Model Mech 2011, 4:318-333.
43. Ito R., Katano I., Kawai K., et al. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice. Transplantation 2009, 87:1654-1658.
44. Nervi B., Rettig M.P., Ritchey J.K., et al. Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice. Exp Hematol 2007, 35:1823-1838.
45. King M.A., Covassin L., Brehm M.A., et al. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol 2009, 157:104-118.
46. Chen X., Chang C.H., Stein R., Cardillo T.M., Gold D.V., Goldenberg D.M. Prevention of acute graft-versus-host disease in a xenogeneic SCID mouse model by the humanized anti-CD74 antagonistic antibody milatuzumab. Biol Blood Marrow Transplant 2013, 19:28-39.
47. Toubai T., Tanaka J., Nishihira J., et al. Effect of macrophage migration inhibitory factor (MIF) on acute graft-versus-host disease in a murine model of allogeneic stem cell transplantation. Transpl Immunol 2006, 16:117-124.
48. Krenger W., Cooke K.R., Crawford J.M., et al. Transplantation of polarized type 2 donor T cells reduces mortality caused by experimental graft-versus-host disease. Transplantation 1996, 62:1278-1285.
49. Andrade D., Redecha P.B., Vukelic M., et al. Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB-RAG-2-/- IL-2Rgamma-/- mice: a promising model for studying human disease. Arthritis Rheum 2011, 63:2764-2773.
50. Greenblatt M.B., Vrbanac V., Tivey T., Tsang K., Tager A.M., Aliprantis A.O. Graft versus host disease in the bone marrow, liver and thymus humanized mouse model. PLoS One 2012, 7:1-9. [e44664].
51. Hogenes M.C., van Dorp S., van Kuik J., et al. Histological assessment of the sclerotic graft-versus-host response in the humanized RAG2-/-gammac-/- mouse model. Biol Blood Marrow Transplant 2012, 18:1023-1035.
52. Pober J.S., Bothwell A.L., Lorber M.I., McNiff J.M., Schechner J.S., Tellides G. Immunopathology of human T cell responses to skin, artery and endothelial cell grafts in the human peripheral blood lymphocyte/severe combined immunodeficient mouse. Springer Semin Immunopathol 2003, 25:167-180.
53. Stehlik J., Edwards L.B., Kucheryavaya A.Y., et al. The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report-2012. J Heart Lung Transplant 2012, 31:1052-1064.
54. Auchincloss H., Sachs D.H. Xenogeneic transplantation. Annu Rev Immunol 1998, 16:433-470.
55. Waldmann H. Transplantation tolerance-where do we stand?. Nat Med 1999, 5:1245-1248.
56. Soleimani B., Katopodis A., Wieczorek G., George A.J., Hornick P.I., Heusser C. Smooth muscle cell proliferation but not neointimal formation is dependent on alloantibody in a murine model of intimal hyperplasia. Clin Exp Immunol 2006, 146:509-517.
57. Mitchell R.N. Graft vascular disease: immune response meets the vessel wall. Annu Rev Pathol 2009, 4:19-47.
58. Onuta G., van Ark J., Rienstra H., et al. Development of transplant vasculopathy in aortic allografts correlates with neointimal smooth muscle cell proliferative capacity and fibrocyte frequency. Atherosclerosis 2010, 209:393-402.
59. Abele-Ohl S., Leis M., Mahmoudian S., Weyand M., Stamminger T., Ensminger S.M. Rag2-/- gamma-chain-/- mice as hosts for human vessel transplantation and allogeneic human leukocyte reconstitution. Transpl Immunol 2010, 23:59-64.
60. Lebastchi A.H., Khan S.F., Qin L., et al. Transforming growth factor beta expression by human vascular cells inhibits interferon gamma production and arterial media injury by alloreactive memory T cells. Am J Transplant 2011, 11:2332-2341.
61. Nadig S.N., Wieckiewicz J., Wu D.C., et al. In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat Med 2010, 16:809-813.
62. Brehm M.A., Shultz L.D. Human allograft rejection in humanized mice: a historical perspective. Cell Mol Immunol 2012, 9:225-231.
63. Anam K., Lazdun Y., Davis P.M., Banas R.A., Elster E.A., Davis T.A. Amnion-derived multipotent progenitor cells support allograft tolerance induction. Am J Transplant 2013, 13:1416-1428.
64. Coluccio A., Miselli F., Lombardo A., et al. Targeted gene addition in human epithelial stem cells by zinc-finger nuclease-mediated homologous recombination. Mol Ther 2013, 21:1695-1704.
65. Wu J.M., Thoburn C.J., Wisell J., Farmer E.R., Hess A.D. CD20, AIF-1, and TGF-beta in graft-versus-host disease: a study of mRNA expression in histologically matched skin biopsies. Mod Pathol 2010, 23:720-728.
66. Tellides G., Tereb D.A., Kirkiles-Smith N.C., et al. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 2000, 403:207-211.
67. Lorber M.I., Wilson J.H., Robert M.E., et al. Human allogeneic vascular rejection after arterial transplantation and peripheral lymphoid reconstitution in severe combined immunodeficient mice. Transplantation 1999, 67:897-903.
68. Feng G., Nadig S.N., Backdahl L., et al. Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection. Sci Transl Med 2011, 3:1-10. [83ra40].
69. Kirkiles-Smith N.C., Harding M.J., Shepherd B.R., et al. Development of a humanized mouse model to study the role of macrophages in allograft injury. Transplantation 2009, 87:189-197.
70. Tateno C., Yoshizane Y., Saito N., et al. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol 2004, 165:901-912.
71. Tsuge M., Hiraga N., Takaishi H., et al. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus. Hepatology 2005, 42:1046-1054.
72. Ohira M., Ishiyama K., Tanaka Y., et al. Adoptive immunotherapy with liver allograft-derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice. J Clin Invest 2009, 119:3226-3235.
73. Chen A.A., Thomas D.K., Ong L.L., Schwartz R.E., Golub T.R., Bhatia S.N. Humanized mice with ectopic artificial liver tissues. Proc Natl Acad Sci U S A 2011, 108:11842-11847.
74. Hasegawa M., Kawai K., Mitsui T., et al. The reconstituted 'humanized liver' in TK-NOG mice is mature and functional. Biochem Biophys Res Commun 2011, 405:405-410.
75. Goldman M.J., Yang Y., Wilson J.M. Gene therapy in a xenograft model of cystic fibrosis lung corrects chloride transport more effectively than the sodium defect. Nat Genet 1995, 9:126-131.
76. Peault B., Tirouvanziam R., Sombardier M.N., Chen S., Perricaudet M., Gaillard D. Gene transfer to human fetal pulmonary tissue developed in immunodeficient SCID mice. Hum Gene Ther 1994, 5:1131-1137.
77. Lim F.Y., Kobinger G.P., Weiner D.J., Radu A., Wilson J.M., Crombleholme T.M. Human fetal trachea-SCID mouse xenografts: efficacy of vesicular stomatitis virus-G pseudotyped lentiviral-mediated gene transfer. J Pediatr Surg 2003, 38:834-839.
78. Keswani S.G., Balaji S., Le L., et al. Pseudotyped AAV vector-mediated gene transfer in a human fetal trachea xenograft model: implications for in utero gene therapy for cystic fibrosis. PLoS One 2012, 7:1-10. [e43633].
79. Keswani S.G., Le L.D., Morris L.M., et al. Submucosal gland development in the human fetal trachea xenograft model: implications for fetal gene therapy. J Pediatr Surg Jan 2011, 46:33-38.
80. Wagnetz D., Sato M., Hirayama S., et al. Rejection of tracheal allograft by intrapulmonary lymphoid neogenesis in the absence of secondary lymphoid organs. Transplantation Jun 27 2012, 93:1212-1220.
81. Su L. Studying human immunology and immunopathology in humanized mice transplanted with human lymphoid tissues and immune cells. Cell Mol Immunol May 2012, 9:191-192.